Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

(Bloomberg) -- Merck KGaA posted earnings that topped estimates as its life science unit recovers from its post-pandemic ...

To support this growth, TileDB opened a new office in New York City, in addition to the company’s current headquarters in Cambridge ... Prior to joining Alexion in 2015, George was employed by Merck & ...

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based ...

Trade, Industry and Energy Minister Ahn Duk-geun, center, poses with foreign businesspeople as Hewlett Packard (HP) and ...

Nearly 500 pupils from four schools became 'sustainability scientists' during a visit from the Curiosity Cube.

ANIP may be acquired soon with a potential offer exceeding $8 billion and contingent on FDA approval of a new drug filed in ...

While the Dow Jones Industrial Average has reached all-time highs recently, one of its newest members, Merck, traded briefly Thursday morning at a 52-week low.

Merck & Co. lowered the top end of its full-year sales forecast after demand for its HPV vaccine fell for a second straight ...

(Reuters) -Merck & Co said on Thursday that weak sales of Gardasil in China are likely to carry over into 2025 as the vaccine's distributor there reduces inventories amid low demand, and the U.S.